Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 7 studies | 31% ± 13% | |
| retina horizontal cell | 5 studies | 36% ± 9% | |
| oligodendrocyte precursor cell | 5 studies | 30% ± 12% | |
| oligodendrocyte | 5 studies | 27% ± 5% | |
| endothelial cell | 4 studies | 29% ± 4% | |
| epithelial cell | 4 studies | 25% ± 4% | |
| GABAergic neuron | 3 studies | 46% ± 7% | |
| glutamatergic neuron | 3 studies | 47% ± 12% | |
| adipocyte | 3 studies | 18% ± 0% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 852.99 | 245 / 245 | 100% | 10.28 | 502 / 502 |
| thymus | 100% | 830.36 | 653 / 653 | 100% | 11.93 | 603 / 605 |
| brain | 100% | 855.63 | 2639 / 2642 | 100% | 14.04 | 702 / 705 |
| breast | 100% | 576.95 | 458 / 459 | 97% | 7.64 | 1085 / 1118 |
| liver | 98% | 456.40 | 222 / 226 | 98% | 5.79 | 398 / 406 |
| ovary | 100% | 1096.72 | 180 / 180 | 96% | 5.81 | 413 / 430 |
| adrenal gland | 98% | 458.78 | 254 / 258 | 97% | 9.06 | 222 / 230 |
| kidney | 100% | 478.33 | 89 / 89 | 92% | 4.88 | 827 / 901 |
| uterus | 99% | 856.91 | 168 / 170 | 87% | 6.61 | 398 / 459 |
| pancreas | 100% | 429.22 | 327 / 328 | 84% | 4.02 | 149 / 178 |
| stomach | 100% | 552.48 | 359 / 359 | 78% | 3.18 | 222 / 286 |
| intestine | 100% | 742.28 | 962 / 966 | 76% | 3.21 | 403 / 527 |
| lung | 97% | 406.11 | 561 / 578 | 76% | 3.56 | 880 / 1155 |
| bladder | 100% | 684.43 | 21 / 21 | 69% | 3.22 | 346 / 504 |
| esophagus | 90% | 571.33 | 1297 / 1445 | 58% | 2.54 | 106 / 183 |
| muscle | 100% | 2099.81 | 803 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 673.02 | 1329 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 99% | 398.84 | 239 / 241 | 0% | 0 | 0 / 0 |
| adipose | 99% | 543.77 | 1194 / 1204 | 0% | 0 | 0 / 0 |
| heart | 96% | 662.02 | 826 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 4.11 | 26 / 29 |
| skin | 46% | 110.83 | 833 / 1809 | 36% | 1.32 | 168 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 67% | 3.62 | 30 / 45 |
| peripheral blood | 35% | 92.72 | 327 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 25% | 1.00 | 20 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0046628 | Biological process | positive regulation of insulin receptor signaling pathway |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | GKAP1 |
| Protein name | G kinase-anchoring protein 1 (cGMP-dependent protein kinase-anchoring protein of 42 kDa) G kinase anchoring protein 1 |
| Synonyms | FKSG21 GKAP42 |
| Description | FUNCTION: Regulates insulin-dependent IRS1 tyrosine phosphorylation in adipocytes by modulating the availability of IRS1 to IR tyrosine kinase. Its association with IRS1 is required for insulin-induced translocation of SLC2A4 to the cell membrane. Involved in TNF-induced impairment of insulin-dependent IRS1 tyrosine phosphorylation. . |
| Accessions | ENST00000376371.7 [Q5VSY0-1] B4DXS0 Q5VSY0 C9J9D2 ENST00000485742.5 ENST00000388782.8 ENST00000376365.7 [Q5VSY0-2] |
